Skip to main content
Advertisement
Advertisement

ACHV

ACHV logo

Achieve Life Sciences, Inc.

7.54
USD
Sponsored
-0.29
-3.70%
Sep 25, 15:59 UTC -4
Closed
exchange

After-Market

7.82

+0.28
+3.74%

ACHV Earnings Reports

Positive Surprise Ratio

ACHV beat 19 of 36 last estimates.

53%

Next Report

Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/
-$0.20
Implied change from Q2 26 (Revenue/ EPS)
--
/
-75.00%
Implied change from Q3 25 (Revenue/ EPS)
--
/
-28.57%

Achieve Life Sciences, Inc. earnings per share and revenue

On Aug 11, 2026, ACHV reported earnings of -0.80 USD per share (EPS) for Q2 26, missing the estimate of -0.15 USD, resulting in a -405.69% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +1.50% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 5 analysts forecast an EPS of -0.20 USD, with revenue projected to reach -- USD, implying an decrease of -75.00% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-
Actual
-$0.54
Surprise
-
FAQ
For Q2 2026, Achieve Life Sciences, Inc. reported EPS of -$0.80, missing estimates by -405.69%, and revenue of $0.00, 0% as expectations.
The stock price moved up 1.5%, changed from $6.67 before the earnings release to $6.77 the day after.
The next earning report is scheduled for Nov 04, 2026.
Based on 5 analysts, Achieve Life Sciences, Inc. is expected to report EPS of -$0.20 and revenue of -- for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement